Altered nerve growth factor level in the optic nerve of patients affected by multiple sclerosis

Multiple Sclerosis

Volumn 5, Issue 6, 1999, Pages 389-394

  Micera, Alessandra ^a   Lambiase, Alessandro ^a,b   Rama, Paolo ^c   Aloe, Luigi ^a  

^a CNR   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c Divisione Medica I   (Italy)

Author keywords

Demyelinating disorders; Multiple sclerosis; NGF; NGFmRNA; Oligodendrocytes; Optic nerve; trkA

Indexed keywords

MESSENGER RNA; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; EARLY DIAGNOSIS; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; OPTIC NERVE; PATHOPHYSIOLOGY;

EID: 0033397950     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859900500i604     Document Type: Article

References (51)

1. Levi-Montalcini R. (1987) The nerve growth factor 35 years later. Science 237: 1154-1162.
2. Connor B, Dragunow M. (1998) The role of neuronal growth factor in neurodegenerative disorders of the human brain. Brain Res Rev 27: 1-39.
3. Levi-Montalcini R, Aloe L, Alleva E. (1990) A role for nerve growth factor in nervous, endocrine and immune systems. PNEI 3: 1-10.
4. Aloe L, Bracci-Laudiero L, Bonini S, Manni L. (1997) The expanding role for nerve growth factor: from neurotrophic to immunologic diseases. Allergy 52: 883-994.
5. Large TH et al. (1989) Structure and developmental expression of the NGF receptor in the chicken central nervous system. Neuron 2: 1123-1134.
6. Carmignoto G et al. (1991) Expression of NGF receptor mRNA in the developing and adult rat retina. Exp Neurobiol 111: 302-311.
7. von Bartheld CS. (1998) Neurotrophins in the developing and regenerating visual system. Histol Histopathol 13: 437-459.
8. Maffei L et al. (1992) Nerve growth factor (NGF) prevents the shift in ocular dominance distribution of visual cortical neurons in monocularly deprived rats. J Neurosci 12: 4651-4662.
9. Siliprandi R, Cannella R, Carmignoto G. (1993) NGF promotes functional recovery of retinal ganglion cells after ischemia. Inv Ophthalmol Vis Sci 34: 3232-3245.
10. Yan HQ, Mazow ML, Dafny N. (1996) NGF prevents the changes induced by monocular deprivation during the critical period in rats. Brain Res 706: 318-322.
11. Carmignoto G, Pizzorusso T, Tia S, Vicini S. (1997) Brain-derived neurotrophic factor and NGF potentiate excitatory synaptic transmission in the rat visual cortex. J Physiol 498: 153-164.
12. Hempstead BL et al. (1991) High affinity NGF binding requires coexpression of the trk proto oncogene and the low affinity NGF receptor. Nature 350: 678-683.
13. Meakin SO, Shooter EM. (1992) The nerve growth factor family of receptors. Trends Neurosci 15: 323-331.
14. Bracci-Laudiero L et al. (1992) Multiple Sclerosis patients express increased levels of β-Nerve Growth Factor in cerebrospinal fluid. Neurosci Lett 147: 9-12.
15. Micera A, De Simone R, Aloe L. (1995) Elevated levels of nerve growth factor in the thalamus and spinal cord of rats affected by experimental allergic encephalomyelitis. Arch Ital Biol 133: 131-142.
16. Calza' L et al. (1997) Time-course of NGF, CRH and NOS isoforms and their possible role in the development of inflammatory response in EAE. Proc Natl Acad Sci USA 94: 3368-3373.
17. Micera A, Vigneti E, Aloe L. (1998) Changes of NGF presence in non neuronal cells in response to experimental allergic encephalomyelitis in Lewis rats. Exp Neurol 154: 41-46.
18. Prineas JW. (1985) Neuropathology of multiple sclerosis. In: Vinken PJ, Bruyn GW and Klawans HL. (eds.), Handbook of clinical neurology. Elsevier: Amsterdam, pp 213-257.
19. Scolding NJ, Zajicek JP, Wood N, Compston DAS. (1994) The pathogenesis of demyelinating disease. Progress Neurobiol 43: 143-173.
20. Navikas V and Link H. (1996) Review: cytokines and the pathogenesis of Multiple Sclerosis. J Neurosci Res 45: 322-333.
21. Navikas V et al. (1996) Augmented expression of tumor necrosis factor-alpha and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis. Brain 119: 213-223.
22. Villaroya H, Violleau K, Ben Younes-Chennoufi A, Baumann N. (1996) Myelin induced experimental allergic encephalomyelitis in Lewis rats: tumor necrosis factor alpha levels in serum and cerebrospinal fluid immunohistochemical expression in glia cells and macrophages of optic nerve and spinal cord. J Neuroimmunol 64: 55-61.
23. Hattori A et al. (1993) Tumor necrosis factor stimulates the synthesis and secretion of biologically active nerve growth factor in non-neuronal cells. J Biol Chem 268: 2577-2582.
24. Aloe L et al. (1994) Nerve growth factor and autoimmune diseases. Autoimmunity 19: 141-150.
25. Cohen RI et al. (1996) Nerve growth factor and neurotrophin-3 differentially regulate the proliferation and survival of developing rat brain oligodendrocytes. J Neurosci 16: 6433-6442.
26. Barres BA et al. (1994) A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 367: 371-375.
27. Byravan S et al. (1994) Murine oligodendroglial cells express nerve growth factor. Proc Natl Acad Sci USA 91: 8812-8816.
28. Althaus HH et al. (1997) Nerve growth factor signal transduction in mature pig oligodendrocytes. J Neurosci Res 50: 729-742.
29. Aloe L, Micera A. (1998) Role of nerve growth factor in oligodendrocyte growth and differentiation of EAE affected rats. Arch Ital Biol 136: 247-256.
30. Raff MC. (1989) Glial cell diversification in the rat optic nerve. Science 243: 1450-1455.
31. Goodkin DE et al. (1991) Diagnostic criteria for multiple sclerosis research involving multiply affected families. Arch Neurol 48: 805-807.
32. Lillie RD. (1965) Histopathologic Technic and Practical Histochemistry. 3rd edition The Blakiston Division, McGraw-Hill Book Company, NY. pp 483.
33. Weskamp G, Otten U (1987) An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and peripheral tissues. J Neurochem 48: 1779-1786.
34. Vigneti E, Bracci-Laudiero L, Aloe L. (1993) Production and characterization of a monoclonal antibody against Nerve growth factor (NGF) which recognizes rodent and human NGF. The Year Immunology Basel Karger 7: 146-149.
35. Martin-Zanca DR et al. (1989) Molecular and biochemical characterization of the human trk proto-oncogene. Mol Cell Biol 9: 24-33.
36. Dissen GA et al. (1996) A role for TRKA nerve growth factor receptors in mammalian ovulation. Endocrinology 137: 198-209.
37. Lugue JM et al. (1998) Procedures for whole-mount immunohistochemistry and in situ hybridization of immature mammalian CNS. Brain Res Prot 2: 165-173.
38. Singer RH, Ward DC. (1982) Actin gene expression visualized in chicken muscle tissue culture by using in situ hybridization with a biotinated nucleotide analog. PNAS 79: 7331-7335.
39. Borsani G et al. (1990) cDNA sequence of human beta-NGF. Nucleic Acids Res 18: 4020-4028.
40. Raine CS et al. (1981) Multiple sclerosis: oligodendrocyte survival and proliferation in an active established lesion. Lab Invest 45: 534-546.
41. Polak M. (1965) Biology of neuroglia. In: Carrea R (ed.) Morphological and functional characteristics of the central and peripheral neuroglia (light microscopical observations), Elsevier: Amsterdam pp 12-34.
42. Leon A et al. (1994) Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci USA 91: 3739-3743.
43. Torcia M et al. (1996) Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 85: 345-356.
44. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV. (1996) Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383: 716-719.
45. Casaccia-Bonnefil P, Kong H, Chao MV. (1998) Neurotrophins: the biological paradox of survival factors eliciting apoptosis. Cell Death Differ 5: 357-364.
46. Ladiwala U et al. (1998) p75 neurotrophin receptor expression on adult human oligodendrocytes: signaling without cell death in response to NGF. J Neurosci 18: 1297-1304.
47. Yoon SO, Casaccia-Bonnefil P, Carter B, Chao MV. (1998) Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. Neurosci 18: 3273-3281.
48. Aloe L. (1997) Nerve growth factor and autoimmune diseases: role of tumor necrosis factor-α? Advances Pharmacol 42: 591-594.
49. Aloe L et al. (1999) Overexpression of tumor necrosis factor-α in the brain of transgenic mice differentially alters nerve growth factor levels and choline acetyl-transferase activity. Cytokine 11: 45-54.
50. Diaz-Villoslada P et al. (1997) Recombinant human NGF prevents autoimmune demyelination in marmosets. Neurology 48: S15.001.
51. Lambiase A et al. (1997) Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension. Graefe's Arch Clin Expt Ophthalmol 235: 780-785.